SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Molecular virology in transfusion medicine laboratory.
16 references·0 citing·23 second hop
Molecular virology in transfusion medicine laboratory. (2013)Molecular virology in transfusion medicin…Surveillance of Transfusion-Transmissible Infections (2011)Surveillance of Transfusion-T…International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009 (2011)International survey on NAT t…Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing (2010)Prevalence, incidence, and re…Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion (2009)Infectivity of human immunode…Impact of individual‐donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa (2009)Impact of individual‐donation…Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions (2009)Experience of mandatory nucle…Emerging infectious disease agents and their potential threat to transfusion safety (2009)Emerging infectious disease a…Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 201 (2008)Comparison of the analytical …A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus (2008)A pilot study for screening b…Hepatitis B virus blood screening: unfinished agendas (2006)Hepatitis B virus blood scree…Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource‐poor settings (2005)Predonation screening of bloo…A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)A new strategy for estimating…High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan (2003)High throughput screening of …Transfusion‐transmitted hepatitis B virus infection in the UK: a small and moving target (2002)Transfusion‐transmitted hepat…The German experience with NAT (2002)The German experience with NATFeasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting (1999)Feasibility and efficacy of r…The Risk of Transfusion-Transmitted Viral Infections (1996)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)Hepatitis B, hepatitis C and HIV transfusion‐transmitted infections in the 21st century (2010)Transfusion‐associated infections: 50 years of relentless challenges and remarkable progress (2010)Donor Testing and Risk: Current Prevalence, Incidence, and Residual Risk of Transfusion-Transmissible Agents in US Allogeneic Donations (2011)Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States (1995)Comparative analysis of triplex nucleic acid test assays in United States blood donors (2013)Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety? (2013)History and Future of Nucleic Acid Amplification Technology Blood Donor Testing (2019)Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors. (2008)Informative Dorfman Screening (2011)Characteristics of blood donors and donated blood in sub‐Saharan Francophone Africa (2009)Seroprevalence of transfusion-transmissible infections and evaluation of the pre-donation screening performance at the Provincial Hospital of Tete, Mozambique (2011)Prevention of transfusion-transmitted infections (2019)Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms (2010)The challenges of meeting the blood transfusion requirements in Sub-Saharan Africa: the need for the development of alternatives to allogenic blood (2011)Problems and Approaches for Blood Transfusion in the Developing Countries (2016)Transfusion-transmitted infections (2007)One‐year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations (2009)Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010 (2012)Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseases (2000)Reducing the risk of infection from plasma products: specific preventative strategies (2000)
this work references cited by second hop

References

  • 2009Emerging infectious disease agents and their potential threat to transfusion safety427 cited
  • 2005A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors426 cited
  • 2010Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing287 cited
  • 1999Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting254 cited
  • 2009Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion221 cited
  • 2011International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009191 cited
  • 2005Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource‐poor settings141 cited
  • 2009Impact of individual‐donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa139 cited
  • 2003High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan101 cited
  • 2006Hepatitis B virus blood screening: unfinished agendas94 cited
  • 2009Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

73 cited
  • 2008A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus64 cited
  • 2008Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 20152 cited
  • 2002The German experience with NAT40 cited
  • 2002Transfusion‐transmitted hepatitis B virus infection in the UK: a small and moving target30 cited
  • 2011Surveillance of Transfusion-Transmissible Infections27 cited
  • Cited by

    No citing works inside the corpus for this window.